Peak expiratory flow rate as predictor of inpatient death in patients with chronic obstructive pulmonary disease

Southern Medical Journal

Volumn 98, Issue 3, 2005, Pages 266-272

  De La Iglesia, Fernando ^a,b   Díaz, José Luis ^a   Pita, Salvador ^a   Nicolás, Ricardo ^a   Ramos, Vicente ^a   Pellicer, Carlos ^a   Diz Lois, Fernando ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b 3a Planta   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Inpatient death; Logistic regression; Peak expiratory flow rate; Receiver operating characteristic curves

Indexed keywords

BRONCHODILATING AGENT;

ACCURACY; ADULT; AGED; ARTERIAL GAS; ARTICLE; BODY MASS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; DISEASE EXACERBATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; LUNG FUNCTION TEST; MALE; OXYGEN THERAPY; PEAK EXPIRATORY FLOW; PREDICTION; RISK;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SOCIAL CLASS; SPAIN;

EID: 15044361946     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000152541.89483.AA     Document Type: Article

References (39)

1. Higgins MW. Chronic airways disease in the United States: trends and determinants. Chest 1989;96(Suppl 3):S328-S334.
2. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveil Summ 2002;51(SS-6):1-16.
3. Comité Científico del Estudio IBERCOP. IBERCOP: valoración de resultados. Arch Bronconeumol 1999;35(Suppl 3):S40-S43.
4. Ward MM, Javitz HS, Smith WM, et al. Direct medical cost of chronic obstructive pulmonary disease in USA. Respir Med 2000;94:1123-1129.
5. Speizer FE. The rise in chronic obstructive pulmonary disease mortality: overview and summary. Am Rev Respir Dis 1989;140(Suppl 3):S106-S107.
6. Chailleux E, Faouroux B, Binet F, et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation: a 10-year analysis of ANTADIR observatory. Chest 1996;109:741-749.
7. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990;11:555-569.
8. Schols AM, Slangen J, Volovics L. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-1797.
9. Ashutosh K, Haldipur C, Boucher ML. Clinical and personality profiles and survival in patients with COPD. Chest 1997;111:95-99.
10. Vestbo J, Prescott E, Lange P, et al. Vital prognosis after hospitalization for COPD: a study of a random population sample. Respir Med 1998;92:772-776.
11. Incalzi RA, Fuso L, De Rosa M, et al. Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999;99:1600-1605.
12. Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy: importance of pulmonary artery pressure. Chest 1995;107:1193-1198.
13. Fuso L, Incalci RA, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995;98:272-277.
14. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT investigators. Am J Respir Crit Care Med 1996;154:956-967.
15. Barberá JA, Peces-Barba G, Agustí AGN, et al. Guía clinica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001;37:297-316.
16. Pauwels RA, Buist AS, Calverley PMA, et al, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Am J Respir Crit Care Med 2001;163:1256-1276.
17. ATS Statement: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152 (Suppl 5):S77-120.
18. Ferris BG. Epidemiology standardization project, II: recommend respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis 1978;118:7-53.
19. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1998;93:580-586.
20. Pratt PC. Role of conventional chest radiography in diagnosis and exclusion of emphysema. Am J Med 1987;82:998-1006.
21. Vandiviere HM. Pulmonary hypertension and cor pulmonale. South Med J 1993;86:2S7-2S10.
22. Siafakas NM, Vermeire P, Pride NB, et al. ERS-Consensus Statement: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398-1420.
23. American Thoracic Society. Standardization of spirometry and PEF: 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
24. Roca J, Sanchis J, Agustí-Vidal A, et al. Spirometric reference values for a Mediterranean population. Bull Eur Physiopathol Respir 1986;22:217-224.
25. Vermeire P. The burden of chronic obstructive pulmonary disease. Respir Med 2002;96(Suppl C):S3-S10.
26. Poole PJ, Bagg B, Brodie SM, et al. Characteristics of patients admitted to hospital with chronic obstructive pulmonary disease. N Z Med J 1997;110:272-275.
27. Mushlin AI, Black ER, Connolly CA, et al. The necessary length of hospital stay for chronic pulmonary disease. JAMA 1991;266:80-83.
28. Neill AM, Epton MJ, Martin IR, et al. An audit of the assessment and management of patients admitted to Christchurch Hospital with chronic obstructive pulmonary disease. N Z Med J 1994;107:365-367.
29. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-685.
30. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980;93:391-398.
31. Wilson DO, Rogers RM, Wright EC, et al. Body weight in chronic obstructive pulmonary disease: National Institutes of Health IPPB Trial. Am Rev Respir Dis 1989;139:1435-1438.
32. De Miguel J, Grau T, Izquierdo JL. Papel de la nutrición en la enfermedad pulmonar obstructive crónica. Med Clín (Barc) 1998;110:307-316.
33. Murata GH, Lium DJ, Busby HK, et al. Precision and accuracy of self-measured peak expiratory flow rates in chronic obstructive pulmonary disease. South Med J 1998;91:919-924.
34. 1. Eur Respir J 1997;10(Suppl 24):S39-S41.
35. Sherwood P. The relationship between peak expiratory flow and respiratory symptoms. Eur Respir J 1997;10(Suppl 24):S67-S68.
36. Murata GH, Kapsner CO, Lium DJ, et al. A multivariate model for predicting respiratory status in patients with chronic obstructive pulmonary disease. J Gen Intern Med 1998;13:462-468.
37. Emerman CL, Cydulka RK. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 1996;27:159-163.
38. Hansen EF, Vestbo J, Phanareth K, et al. Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:690-693.
39. Burgueño MJ, García-Bastos JL, González-Buitrago JM. Las curvas ROC en la evaluación de las pruebas diagnósticas. Med Clin (Barc) 1995;104:661-670.